Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.0%, Underperforms Peers
Dow Jones2026/10/01 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slipped 7.0% to $6.34 on what proved to be an all-around mediocre trading session for the stock market, with the NASDAQ Composite Index holding mostly steady at 26,871.60 and the Dow Jones Industrial Average remaining mostly unchanged at 50,926.56.
Corbus Pharmaceuticals Holdings Inc. closed 69.2% below its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 2.0% to $4.81, Fortress Biotech Inc. fell 3.3% to $2.07, and Viking Therapeutics Inc. fell 6.41% to $30.51.
Trading volume totaled 802,294, compared to the 50-day average of 815,766.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 01, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nvidia’s $1 Billion Option Dispute: Does This Early Advisor Have a Case?
RWA active management scale has increased by more than 15 billion dollars in 9 months
Crypto prices
More
